{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:41:49Z","timestamp":1792543309310,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"DOI":"10.7759\/cureus.42259","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:16:53Z","timestamp":1689938213000},"source":"Crossref","is-referenced-by-count":14,"title":["Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration"],"prefix":"10.7759","author":[{"given":"Hussam","family":"Alkaissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy I.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000345461","article-title":"Bone mineral density as a predictor of atherosclerosis and arterial wall stiffness in obese African-American women","volume":"2","author":"McFarlane SI","year":"2012","unstructured":"McFarlane SI, Qureshi G, Singh G, Venner-Jones K, Salciccioli L, Lazar J. Bone mineral density as a predictor of atherosclerosis and arterial wall stiffness in obese African-American women. Cardiorenal Med. 2012, 2:328-34. 10.1159\/000345461","journal-title":"Cardiorenal Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:23:1:01","article-title":"Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?","volume":"23","author":"McFarlane SI","year":"2004","unstructured":"McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?. Endocrine. 2004, 23:1-10. 10.1385\/ENDO:23:1:01","journal-title":"Endocrine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.0197-3118.2006.05457.x","article-title":"Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights","volume":"1","author":"McFarlane SI","year":"2006","unstructured":"McFarlane SI. Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights. J Cardiometab Syndr. 2006, 1:53-7. 10.1111\/j.0197-3118.2006.05457.x","journal-title":"J Cardiometab Syndr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.37.195.505","article-title":"Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland","volume":"37","author":"CA NA","year":"1962","unstructured":"CA NA, NE DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962, 37:505-13. 10.1136\/adc.37.195.505","journal-title":"Arch Dis Child"},{"key":"ref5","article-title":"Homocystinuria: an enzymatic defect","volume":"143","author":"Mudd SH","year":"1964","unstructured":"Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science. 1964, 143:1443-5.","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.09.009","article-title":"A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"99","author":"Skovby F","year":"2010","unstructured":"Skovby F, Gaustadnes M, Mudd SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab. 2010, 99:1-3. 10.1016\/j.ymgme.2009.09.009","journal-title":"Mol Genet Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/301640","article-title":"The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population","volume":"61","author":"Matsushita S","year":"1997","unstructured":"Matsushita S, Muramatsu T, Arai H, Matsui T, Higuchi S. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet. 1997, 61:1459-60. 10.1086\/301640","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200283","article-title":"Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR)","volume":"7","author":"Heijmans BT","year":"1999","unstructured":"Heijmans BT, Gussekloo J, Kluft C, et al.. Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR). Eur J Hum Genet. 1999, 7:197-204. 10.1038\/sj.ejhg.5200283","journal-title":"Eur J Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem337","article-title":"Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss","volume":"22","author":"Callej\u00f3n G","year":"2007","unstructured":"Callej\u00f3n G, Mayor-Olea A, Jim\u00e9nez AJ, et al.. Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss. Hum Reprod. 2007, 22:3249-54. 10.1093\/humrep\/dem337","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-9-104","article-title":"Human genetic selection on the MTHFR 677C>T polymorphism","volume":"9","author":"Mayor-Olea A","year":"2008","unstructured":"Mayor-Olea A, Callej\u00f3n G, Palomares AR, et al.. Human genetic selection on the MTHFR 677C>T polymorphism. BMC Med Genet. 2008, 9:104. 10.1186\/1471-2350-9-104","journal-title":"BMC Med Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.12.007","article-title":"Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials","volume":"222","author":"Qin X","year":"2012","unstructured":"Qin X, Xu M, Zhang Y, et al.. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012, 222:307-13. 10.1016\/j.atherosclerosis.2011.12.007","journal-title":"Atherosclerosis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980014002134","article-title":"The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis","volume":"18","author":"Zeng R","year":"2015","unstructured":"Zeng R, Xu CH, Xu YN, Wang YL, Wang M. The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis. Public Health Nutr. 2015, 18:1514-21. 10.1017\/S1368980014002134","journal-title":"Public Health Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003768","article-title":"Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"5","author":"Li Y","year":"2016","unstructured":"Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016, 5:10.1161\/JAHA.116.003768","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/2326409817698994","article-title":"The link between hyperhomocysteinemia and hypomethylation: implications for cardiovascular disease","volume":"5","author":"Barroso M","year":"2017","unstructured":"Barroso M, Handy DE, Castro R. The link between hyperhomocysteinemia and hypomethylation: implications for cardiovascular disease. J Inborn Errors Metab Screen. 2017, 5:10.1177\/2326409817698994","journal-title":"J Inborn Errors Metab Screen"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100029200","article-title":"Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases. Evidence from 31P NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme","volume":"276","author":"Kabil O","year":"2001","unstructured":"Kabil O, Toaka S, LoBrutto R, Shoemaker R, Banerjee R. Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases. Evidence from 31P NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme. J Biol Chem. 2001, 276:19350-5. 10.1074\/jbc.M100029200","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00282.2005","article-title":"CBS domains: structure, function, and pathology in human proteins","volume":"289","author":"Ignoul S","year":"2005","unstructured":"Ignoul S, Eggermont J. CBS domains: structure, function, and pathology in human proteins. Am J Physiol Cell Physiol. 2005, 289:C1369-78. 10.1152\/ajpcell.00282.2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8940321","article-title":"A clinically relevant variant of the human hydrogen sulfide-synthesizing enzyme cystathionine \u03b2-synthase: Increased CO reactivity as a novel molecular mechanism of pathogenicity?","volume":"2017","author":"Vicente JB","year":"2017","unstructured":"Vicente JB, Cola\u00e7o HG, Malagrin\u00f2 F, et al.. A clinically relevant variant of the human hydrogen sulfide-synthesizing enzyme cystathionine \u03b2-synthase: Increased CO reactivity as a novel molecular mechanism of pathogenicity?. Oxid Med Cell Longev. 2017, 2017:8940321. 10.1155\/2017\/8940321","journal-title":"Oxid Med Cell Longev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212376200","article-title":"Tumor necrosis factor-alpha-induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis","volume":"278","author":"Zou CG","year":"2003","unstructured":"Zou CG, Banerjee R. Tumor necrosis factor-alpha-induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis. J Biol Chem. 2003, 278:16802-8. 10.1074\/jbc.M212376200","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00598.2010","article-title":"Vascular complications of cystathionine \u03b2-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research","volume":"300","author":"Beard RS Jr","year":"2011","unstructured":"Beard RS Jr, Bearden SE. Vascular complications of cystathionine \u03b2-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol. 2011, 300:H13-26. 10.1152\/ajpheart.00598.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2014.10.004","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases","volume":"58","author":"Liew SC","year":"2015","unstructured":"Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015, 58:1-10. 10.1016\/j.ejmg.2014.10.004","journal-title":"Eur J Med Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.62","article-title":"Update on cobalamin, folate, and homocysteine","author":"Carmel R","year":"2003","unstructured":"Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program. 2003, 62-81. 10.1182\/asheducation-2003.1.62","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer M","year":"2017","unstructured":"Huemer M, Diodato D, Schwahn B, et al.. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017, 40:21-48. 10.1007\/s10545-016-9991-4","journal-title":"J Inherit Metab Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/280518","article-title":"Recent development in production and biotechnological application of microbial enzymes","volume":"2015","author":"Hmidet N","year":"2015","unstructured":"Hmidet N, Nawani N, Ghorbel S. Recent development in production and biotechnological application of microbial enzymes. Biomed Res Int. 2015, 2015:280518. 10.1155\/2015\/280518","journal-title":"Biomed Res Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-017-2494-2","article-title":"The role of methionine on metabolism, oxidative stress, and diseases","volume":"49","author":"Mart\u00ednez Y","year":"2017","unstructured":"Mart\u00ednez Y, Li X, Liu G, et al.. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids. 2017, 49:2091-8. 10.1007\/s00726-017-2494-2","journal-title":"Amino Acids"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker GS","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017, 25:27-42. 10.1016\/j.cmet.2016.08.009","journal-title":"Cell Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091987","article-title":"Serine metabolism in health and disease and as a conditionally essential amino acid","volume":"14","author":"Hole\u010dek M","year":"2022","unstructured":"Hole\u010dek M. Serine metabolism in health and disease and as a conditionally essential amino acid. Nutrients. 2022, 14:1987. 10.3390\/nu14091987","journal-title":"Nutrients"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao BS","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017, 18:31-42. 10.1038\/nrm.2016.132","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.028","article-title":"Methyl donor deficiency impairs fatty acid oxidation through PGC-1\u03b1 hypomethylation and decreased ER-\u03b1, ERR-\u03b1, and HNF-4\u03b1 in the rat liver","volume":"57","author":"Pooya S","year":"2012","unstructured":"Pooya S, Blaise S, Moreno Garcia M, et al.. Methyl donor deficiency impairs fatty acid oxidation through PGC-1\u03b1 hypomethylation and decreased ER-\u03b1, ERR-\u03b1, and HNF-4\u03b1 in the rat liver. J Hepatol. 2012, 57:344-51. 10.1016\/j.jhep.2012.03.028","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/path.2881","article-title":"Methyl donor deficiency induces cardiomyopathy through altered methylation\/acetylation of PGC-1\u03b1 by PRMT1 and SIRT1","volume":"225","author":"Garcia MM","year":"2011","unstructured":"Garcia MM, Gu\u00e9ant-Rodriguez RM, Pooya S, et al.. Methyl donor deficiency induces cardiomyopathy through altered methylation\/acetylation of PGC-1\u03b1 by PRMT1 and SIRT1. J Pathol. 2011, 225:324-35. 10.1002\/path.2881","journal-title":"J Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133140","article-title":"Dysregulation of epigenetic mechanisms of gene expression in the pathologies of hyperhomocysteinemia","volume":"20","author":"Per\u0142a-Kaj\u00e1n J","year":"2019","unstructured":"Per\u0142a-Kaj\u00e1n J, Jakubowski H. Dysregulation of epigenetic mechanisms of gene expression in the pathologies of hyperhomocysteinemia. Int J Mol Sci. 2019, 20:3140. 10.3390\/ijms20133140","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9958-5","article-title":"Lack of global epigenetic methylation defects in CBS deficient mice","volume":"40","author":"Lee HO","year":"2017","unstructured":"Lee HO, Wang L, Kuo YM, et al.. Lack of global epigenetic methylation defects in CBS deficient mice. J Inherit Metab Dis. 2017, 40:113-20. 10.1007\/s10545-016-9958-5","journal-title":"J Inherit Metab Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0753-3322(01)00085-3","article-title":"Protein N-homocysteinylation: implications for atherosclerosis","volume":"55","author":"Jakubowski H","year":"2001","unstructured":"Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis.  Biomed Pharmacother. 2001, 55:443-7. 10.1016\/s0753-3322(01)00085-3","journal-title":"Biomed Pharmacother"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski H","year":"1999","unstructured":"Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999, 13:2277-83.","journal-title":"FASEB J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1574-1","article-title":"Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction","volume":"45","author":"Genoud V","year":"2018","unstructured":"Genoud V, Quintana PG, Gionco S, Baldessari A, Quintana I. Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction. J Thromb Thrombolysis. 2018, 45:66-76. 10.1007\/s11239-017-1574-1","journal-title":"J Thromb Thrombolysis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600539","article-title":"N-Homocysteinylation impairs collagen cross-linking in cystathionine \u03b2-synthase-deficient mice: a novel mechanism of connective tissue abnormalities","volume":"30","author":"Per\u0142a-Kajan J","year":"2016","unstructured":"Per\u0142a-Kajan J, Utyro O, Rusek M, Malinowska A, Sitkiewicz E, Jakubowski H. N-Homocysteinylation impairs collagen cross-linking in cystathionine \u03b2-synthase-deficient mice: a novel mechanism of connective tissue abnormalities. FASEB J. 2016, 30:3810-21. 10.1096\/fj.201600539","journal-title":"FASEB J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1039\/c8sc00221e","article-title":"Chemical proteomic profiling of protein N-homocysteinylation with a thioester probe","volume":"9","author":"Chen N","year":"2018","unstructured":"Chen N, Liu J, Qiao Z, et al.. Chemical proteomic profiling of protein N-homocysteinylation with a thioester probe. Chem Sci. 2018, 9:2826-30. 10.1039\/c8sc00221e","journal-title":"Chem Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00937","article-title":"Proteome-wide analysis of protein lysine n-homocysteinylation in saccharomyces cerevisiae","volume":"20","author":"Perl A-Kaj\u00e1n J","year":"2021","unstructured":"Perl A-Kaj\u00e1n J, Malinowska A, Zimny JA, Cysewski D, Suszy\u0144ska-Zajczyk J, Jakubowski H. Proteome-wide analysis of protein lysine n-homocysteinylation in saccharomyces cerevisiae. J Proteome Res. 2021, 20:2458-76. 10.1021\/acs.jproteome.0c00937","journal-title":"J Proteome Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully KS","year":"2015","unstructured":"McCully KS. Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol. 2015, 8:211-9. 10.1586\/17512433.2015.1010516","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam YT","year":"2013","unstructured":"Ghebremariam YT, LePendu P, Lee JC, et al.. Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013, 128:845-53. 10.1161\/CIRCULATIONAHA.113.003602","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.6515\/ACS.201903_35(2).20180917A","article-title":"Blockade of cardiac proton pump impairs ventricular remodeling through a superoxide-DDAH-dependent pathway in infarcted rats","volume":"35","author":"Chen WT","year":"2019","unstructured":"Chen WT, Shie CB, Yang CC, Lee TM. Blockade of cardiac proton pump impairs ventricular remodeling through a superoxide-DDAH-dependent pathway in infarcted rats. Acta Cardiol Sin. 2019, 35:165-78. 10.6515\/ACS.201903_35(2).20180917A","journal-title":"Acta Cardiol Sin"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2504","article-title":"Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: a cross-sectional study","volume":"41","author":"Nolde M","year":"2021","unstructured":"Nolde M, Bahls M, Friedrich N, et al.. Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: a cross-sectional study. Pharmacotherapy. 2021, 41:198-204. 10.1002\/phar.2504","journal-title":"Pharmacotherapy"},{"key":"ref42","article-title":"Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells","volume":"68","author":"Jia SJ","year":"2013","unstructured":"Jia SJ, Lai YQ, Zhao M, Gong T, Zhang BK. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells. Pharmazie. 2013, 68:282-6.","journal-title":"Pharmazie"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine","volume":"104","author":"St\u00fchlinger MC","year":"2001","unstructured":"St\u00fchlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001, 104:2569-75. 10.1161\/hc4601.098514","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1159\/000343329","article-title":"Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH\/ADMA\/NOS\/NO pathway in endothelial cells","volume":"30","author":"Liu LH","year":"2012","unstructured":"Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH\/ADMA\/NOS\/NO pathway in endothelial cells. Cell Physiol Biochem. 2012, 30:1413-22. 10.1159\/000343329","journal-title":"Cell Physiol Biochem"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-0892-4","article-title":"Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria","volume":"42","author":"Kanzelmeyer N","year":"2012","unstructured":"Kanzelmeyer N, Tsikas D, Chobanyan-J\u00fcrgens K, et al.. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria. Amino Acids. 2012, 42:1765-72. 10.1007\/s00726-011-0892-4","journal-title":"Amino Acids"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.03.009","article-title":"Asymmetric dimethylarginine in adults with cystathionine \u03b2-synthase deficiency","volume":"222","author":"Rocha MS","year":"2012","unstructured":"Rocha MS, Teerlink T, Janssen MC, et al.. Asymmetric dimethylarginine in adults with cystathionine \u03b2-synthase deficiency. Atherosclerosis. 2012, 222:509-11. 10.1016\/j.atherosclerosis.2012.03.009","journal-title":"Atherosclerosis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0208-0","article-title":"Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function","volume":"29","author":"Wilcken DE","year":"2006","unstructured":"Wilcken DE, Wang J, Sim AS, Green K, Wilcken B. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. J Inherit Metab Dis. 2006, 29:30-7. 10.1007\/s10545-006-0208-0","journal-title":"J Inherit Metab Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2019.00049","article-title":"Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies","volume":"6","author":"Tinelli C","year":"2019","unstructured":"Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019, 6:49. 10.3389\/fnut.2019.00049","journal-title":"Front Nutr"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140715074","article-title":"Defective homocysteine metabolism: potential implications for skeletal muscle malfunction","volume":"14","author":"Veeranki S","year":"2013","unstructured":"Veeranki S, Tyagi SC. Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci. 2013, 14:15074-91. 10.3390\/ijms140715074","journal-title":"Int J Mol Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096701","article-title":"Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene","volume":"110","author":"Jamaluddin MD","year":"2007","unstructured":"Jamaluddin MD, Chen I, Yang F, et al.. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood. 2007, 110:3648-55. 10.1182\/blood-2007-06-096701","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-5-1","article-title":"Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies","volume":"5","author":"Sharma P","year":"2006","unstructured":"Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 2006, 5:1. 10.1186\/1476-511X-5-1","journal-title":"Lipids Health Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2005.01.011","article-title":"Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression","volume":"21","author":"Su SJ","year":"2005","unstructured":"Su SJ, Huang LW, Pai LS, Liu HW, Chang KL. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition. 2005, 21:994-1002. 10.1016\/j.nut.2005.01.011","journal-title":"Nutrition"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease","volume":"103","author":"Poddar R","year":"2001","unstructured":"Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001, 103:2717-23. 10.1161\/01.cir.103.22.2717","journal-title":"Circulation"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00555.2010","article-title":"Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress","volume":"299","author":"Bearden SE","year":"2010","unstructured":"Bearden SE, Beard RS Jr, Pfau JC. Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress. Am J Physiol Heart Circ Physiol. 2010, 299:H1568-76. 10.1152\/ajpheart.00555.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/biom9100610","article-title":"Emerging roles of lysyl oxidases in the cardiovascular system: new concepts and therapeutic challenges","volume":"9","author":"Mart\u00ednez-Gonz\u00e1lez J","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez J, Varona S, Ca\u00f1es L, Gal\u00e1n M, Briones AM, Cachofeiro V, Rodr\u00edguez C. Emerging roles of lysyl oxidases in the cardiovascular system: new concepts and therapeutic challenges. Biomolecules. 2019, 9:610. 10.3390\/biom9100610","journal-title":"Biomolecules"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12228","article-title":"The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions","volume":"276","author":"Ovchinnikova OA","year":"2014","unstructured":"Ovchinnikova OA, Folkersen L, Persson J, et al.. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. J Intern Med. 2014, 276:525-36. 10.1111\/joim.12228","journal-title":"J Intern Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030718","article-title":"Betaine supplementation attenuates S-adenosylhomocysteine hydrolase-deficiency-accelerated atherosclerosis in apolipoprotein E-deficient mice","volume":"14","author":"Dai X","year":"2022","unstructured":"Dai X, Liu S, Cheng L, et al.. Betaine supplementation attenuates S-adenosylhomocysteine hydrolase-deficiency-accelerated atherosclerosis in apolipoprotein E-deficient mice. Nutrients. 2022, 14:718. 10.3390\/nu14030718","journal-title":"Nutrients"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-009-0003-4","article-title":"Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice","volume":"48","author":"Lv S","year":"2009","unstructured":"Lv S, Fan R, Du Y, Hou M, Tang Z, Ling W, Zhu H. Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. Eur J Nutr. 2009, 48:205-12. 10.1007\/s00394-009-0003-4","journal-title":"Eur J Nutr"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(95)90867-f","article-title":"Thrombomodulin and ristocetincofactor in homocystinuria: a study in two siblings","volume":"77","author":"Schienle HW","year":"1995","unstructured":"Schienle HW, Seitz R, Nawroth P, et al.. Thrombomodulin and ristocetincofactor in homocystinuria: a study in two siblings. Thromb Res. 1995, 77:79-86. 10.1016\/0049-3848(95)90867-f","journal-title":"Thromb Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1021\/bi052076j","article-title":"Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia","volume":"45","author":"Sauls DL","year":"2006","unstructured":"Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry. 2006, 45:2480-7. 10.1021\/bi052076j","journal-title":"Biochemistry"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009733.pub3","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders","volume":"3","author":"Estcourt LJ","year":"2016","unstructured":"Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database Syst Rev. 2016, 3:CD009733. 10.1002\/14651858.CD009733.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199412000-00002","article-title":"Coagulation factors and markers of activation of coagulation in homocystinuria (HOCY): a study in two siblings","volume":"5","author":"Schienle HW","year":"1994","unstructured":"Schienle HW, Seitz R, Rohner I, et al.. Coagulation factors and markers of activation of coagulation in homocystinuria (HOCY): a study in two siblings. Blood Coagul Fibrinolysis. 1994, 5:873-8. 10.1097\/00001721-199412000-00002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032546","article-title":"Homocysteine levels and the risk of osteoporotic fracture","volume":"350","author":"van Meurs JB","year":"2004","unstructured":"van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al.. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004, 350:2033-41. 10.1056\/NEJMoa032546","journal-title":"N Engl J Med"},{"key":"ref64","article-title":"Homocysteine as a predictive factor for hip fracture in older persons","volume":"351","author":"Ellenberg SS","year":"2004","unstructured":"Ellenberg SS, Orloff DG, Temple RJ. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004, 351:1027-30.","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2005.194","article-title":"Homocysteine--a newly recognised risk factor for osteoporosis","volume":"43","author":"Herrmann M","year":"2005","unstructured":"Herrmann M, Widmann T, Herrmann W. Homocysteine--a newly recognised risk factor for osteoporosis. Clin Chem Lab Med. 2005, 43:1111-7. 10.1515\/CCLM.2005.194","journal-title":"Clin Chem Lab Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(00)00548-7","article-title":"Atherosclerosis, type 1 collagen cross-linking and homocysteine","volume":"152","author":"Bode MK","year":"2000","unstructured":"Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T. Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis. 2000, 152:531-2. 10.1016\/s0021-9150(00)00548-7","journal-title":"Atherosclerosis"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100669","article-title":"A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia","volume":"9","author":"Khosravi R","year":"2014","unstructured":"Khosravi R, Sodek KL, Xu WP, Bais MV, Saxena D, Faibish M, Trackman PC. A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia. PLoS One. 2014, 9:e100669. 10.1371\/journal.pone.0100669","journal-title":"PLoS One"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2384","article-title":"Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells","volume":"36","author":"Sharma-Bhandari A","year":"2015","unstructured":"Sharma-Bhandari A, Park SH, Kim JY, Oh J, Kim Y. Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells. Int J Mol Med. 2015, 36:1664-70. 10.3892\/ijmm.2015.2384","journal-title":"Int J Mol Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.51.32370","article-title":"Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria","volume":"272","author":"Liu G","year":"1997","unstructured":"Liu G, Nellaiappan K, Kagan HM. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem. 1997, 272:32370-7. 10.1074\/jbc.272.51.32370","journal-title":"J Biol Chem"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25693","article-title":"Homocysteine as a pathological biomarker for bone disease","volume":"232","author":"Behera J","year":"2017","unstructured":"Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N. Homocysteine as a pathological biomarker for bone disease. J Cell Physiol. 2017, 232:2704-9. 10.1002\/jcp.25693","journal-title":"J Cell Physiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2005.03.004","article-title":"Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells","volume":"1740","author":"Sakamoto W","year":"2005","unstructured":"Sakamoto W, Isomura H, Fujie K, Deyama Y, Kato A, Nishihira J, Izumi H. Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta. 2005, 1740:12-6. 10.1016\/j.bbadis.2005.03.004","journal-title":"Biochim Biophys Acta"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.584147","article-title":"Sclerostin and osteocalcin: candidate bone-produced hormones","volume":"12","author":"Wang JS","year":"2021","unstructured":"Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: candidate bone-produced hormones. Front Endocrinol (Lausanne). 2021, 12:584147. 10.3389\/fendo.2021.584147","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64482-3","article-title":"Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification","volume":"161","author":"Steitz SA","year":"2002","unstructured":"Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2002, 161:2035-46. 10.1016\/S0002-9440(10)64482-3","journal-title":"Am J Pathol"},{"key":"ref74","article-title":"The link between osteoporosis and cardiovascular disease","volume":"5","author":"Farhat GN","year":"2008","unstructured":"Farhat GN, Cauley JA. The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab. 2008, 5:19-34.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.6A7087.2006","article-title":"Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice","volume":"55","author":"Kaartinen MT","year":"2007","unstructured":"Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem. 2007, 55:375-86. 10.1369\/jhc.6A7087.2006","journal-title":"J Histochem Cytochem"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600332R","article-title":"Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1-dependent vitamin D receptor pathway","volume":"30","author":"Feigerlova E","year":"2016","unstructured":"Feigerlova E, Demarquet L, Melhem H, et al.. Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1-dependent vitamin D receptor pathway. FASEB J. 2016, 30:3598-612. 10.1096\/fj.201600332R","journal-title":"FASEB J"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.06.009","article-title":"Hydrogen sulfide epigenetically mitigates bone loss through OPG\/RANKL regulation during hyperhomocysteinemia in mice","volume":"114","author":"Behera J","year":"2018","unstructured":"Behera J, George AK, Voor MJ, Tyagi SC, Tyagi N. Hydrogen sulfide epigenetically mitigates bone loss through OPG\/RANKL regulation during hyperhomocysteinemia in mice. Bone. 2018, 114:90-108. 10.1016\/j.bone.2018.06.009","journal-title":"Bone"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1233-5","article-title":"Betaine promotes cell differentiation of human osteoblasts in primary culture","volume":"15","author":"Villa I","year":"2017","unstructured":"Villa I, Senesi P, Montesano A, et al.. Betaine promotes cell differentiation of human osteoblasts in primary culture. J Transl Med. 2017, 15:132. 10.1186\/s12967-017-1233-5","journal-title":"J Transl Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010231","article-title":"The controversial role of homocysteine in neurology: From labs to clinical practice","volume":"20","author":"Moretti R","year":"2019","unstructured":"Moretti R, Caruso P. The controversial role of homocysteine in neurology: From labs to clinical practice. Int J Mol Sci. 2019, 20:231. 10.3390\/ijms20010231","journal-title":"Int J Mol Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.02.027","article-title":"Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study","volume":"216","author":"Kloppenborg RP","year":"2011","unstructured":"Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis. 2011, 216:461-6. 10.1016\/j.atherosclerosis.2011.02.027","journal-title":"Atherosclerosis"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5523453","article-title":"Obsessive-compulsive symptoms as a manifestation of homocystinuria","volume":"2021","author":"Froes V","year":"2021","unstructured":"Froes V, Afonso H, Gameiro Z. Obsessive-compulsive symptoms as a manifestation of homocystinuria. Case Rep Psychiatry. 2021, 2021:5523453. 10.1155\/2021\/5523453","journal-title":"Case Rep Psychiatry"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600915R","article-title":"The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice","volume":"31","author":"Khayati K","year":"2017","unstructured":"Khayati K, Antikainen H, Bonder EM, Weber GF, Kruger WD, Jakubowski H, Dobrowolski R. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice. FASEB J. 2017, 31:598-609. 10.1096\/fj.201600915R","journal-title":"FASEB J"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1177\/2155179017722280","article-title":"Therapeutic cocktail approach for treatment of hyperhomocysteinemia in Alzheimer\u2019s disease","volume":"10","author":"Leon M","year":"2018","unstructured":"Leon M, Sawmiller D, Shytle RD, Tan J. Therapeutic cocktail approach for treatment of hyperhomocysteinemia in Alzheimer\u2019s disease. Cell Med. 2018, 10:2155179017722280. 10.1177\/2155179017722280","journal-title":"Cell Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0216-z","article-title":"Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver","volume":"9","author":"Yang A","year":"2018","unstructured":"Yang A, Jiao Y, Yang S, et al.. Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver. Cell Death Dis. 2018, 9:169. 10.1038\/s41419-017-0216-z","journal-title":"Cell Death Dis"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-016-2302-4","article-title":"Mechanistic basis of hypermethioninemia","volume":"48","author":"Schweinberger BM","year":"2016","unstructured":"Schweinberger BM, Wyse AT. Mechanistic basis of hypermethioninemia. Amino Acids. 2016, 48:2479-89. 10.1007\/s00726-016-2302-4","journal-title":"Amino Acids"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2014.05.015","article-title":"Body composition in patients with classical homocystinuria: body mass relates to homocysteine and choline metabolism","volume":"546","author":"Poloni S","year":"2014","unstructured":"Poloni S, Leistner-Segal S, Bandeira IC, et al.. Body composition in patients with classical homocystinuria: body mass relates to homocysteine and choline metabolism. Gene. 2014, 546:443-7. 10.1016\/j.gene.2014.05.015","journal-title":"Gene"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.2741\/997","article-title":"Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases","volume":"8","author":"Bian K","year":"2003","unstructured":"Bian K, Murad F. Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases. Front Biosci. 2003, 8:d264-78. 10.2741\/997","journal-title":"Front Biosci"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.3074","article-title":"Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders","volume":"13","author":"Calabrese V","year":"2010","unstructured":"Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. 2010, 13:1763-811. 10.1089\/ars.2009.3074","journal-title":"Antioxid Redox Signal"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7009","article-title":"Biogenesis of hydrogen sulfide and thioethers by cystathionine beta-synthase","volume":"28","author":"Majtan T","year":"2018","unstructured":"Majtan T, Krijt J, Sokolov\u00e1 J, et al.. Biogenesis of hydrogen sulfide and thioethers by cystathionine beta-synthase. Antioxid Redox Signal. 2018, 28:311-23. 10.1089\/ars.2017.7009","journal-title":"Antioxid Redox Signal"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/biom10050697","article-title":"Cystathionine-\u03b2-synthase: molecular regulation and pharmacological inhibition","volume":"10","author":"Zuhra K","year":"2020","unstructured":"Zuhra K, Augsburger F, Majtan T, Szabo C. Cystathionine-\u03b2-synthase: molecular regulation and pharmacological inhibition. Biomolecules. 2020, 10:697. 10.3390\/biom10050697","journal-title":"Biomolecules"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28599-9","article-title":"ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1","volume":"13","author":"Statzer C","year":"2022","unstructured":"Statzer C, Meng J, Venz R, et al.. ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1. Nat Commun. 2022, 13:967. 10.1038\/s41467-022-28599-9","journal-title":"Nat Commun"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.001","article-title":"Amino acid restriction triggers angiogenesis via GCN2\/ATF4 regulation of VEGF and H2S production","volume":"173","author":"Longchamp A","year":"2018","unstructured":"Longchamp A, Mirabella T, Arduini A, et al.. Amino acid restriction triggers angiogenesis via GCN2\/ATF4 regulation of VEGF and H2S production. Cell. 2018, 173:117-129.e14. 10.1016\/j.cell.2018.03.001","journal-title":"Cell"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00598","article-title":"Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction","volume":"10","author":"Kar S","year":"2019","unstructured":"Kar S, Shahshahan HR, Kambis TN, Yadav SK, Li Z, Lefer DJ, Mishra PK. Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction. Front Physiol. 2019, 10:598. 10.3389\/fphys.2019.00598","journal-title":"Front Physiol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200905143550","article-title":"Role of hydrogen sulfide and polysulfides in neurological diseases: Focus on protein S-Persulfidation","volume":"19","author":"Sun HJ","year":"2021","unstructured":"Sun HJ, Wu ZY, Nie XW, Bian JS. Role of hydrogen sulfide and polysulfides in neurological diseases: Focus on protein S-Persulfidation. Curr Neuropharmacol. 2021, 19:868-84. 10.2174\/1570159X18666200905143550","journal-title":"Curr Neuropharmacol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.674135","article-title":"The role of protein persulfidation in brain aging and neurodegeneration","volume":"13","author":"Petrovic D","year":"2021","unstructured":"Petrovic D, Kouroussis E, Vignane T, Filipovic MR. The role of protein persulfidation in brain aging and neurodegeneration. Front Aging Neurosci. 2021, 13:674135. 10.3389\/fnagi.2021.674135","journal-title":"Front Aging Neurosci"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.661601","article-title":"H2S donor and bone metabolism","volume":"12","author":"Hao Y","year":"2021","unstructured":"Hao Y, Wang H, Fang L, Bian J, Gao Y, Li C. H2S donor and bone metabolism. Front Pharmacol. 2021, 12:661601. 10.3389\/fphar.2021.661601","journal-title":"Front Pharmacol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14523","article-title":"Metabolism of sulfur compounds in homocystinurias","volume":"176","author":"Ko\u017eich V","year":"2019","unstructured":"Ko\u017eich V, Ditr\u00f3i T, Sokolov\u00e1 J, K\u0159\u00ed\u017ekov\u00e1 M, Krijt J, Je\u0161ina P, Nagy P. Metabolism of sulfur compounds in homocystinurias. Br J Pharmacol. 2019, 176:594-606. 10.1111\/bph.14523","journal-title":"Br J Pharmacol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2016.01.001","article-title":"Thioethers as markers of hydrogen sulfide production in homocystinurias","volume":"126","author":"Ko\u017eich V","year":"2016","unstructured":"Ko\u017eich V, Krijt J, Sokolov\u00e1 J, et al.. Thioethers as markers of hydrogen sulfide production in homocystinurias. Biochimie. 2016, 126:14-20. 10.1016\/j.biochi.2016.01.001","journal-title":"Biochimie"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101550R","article-title":"Homozygous whole body Cbs knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia","volume":"36","author":"Nakladal D","year":"2022","unstructured":"Nakladal D, Lambooy SP, Mi\u0161\u00fath S, et al.. Homozygous whole body Cbs knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia. FASEB J. 2022, 36:e22260. 10.1096\/fj.202101550R","journal-title":"FASEB J"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H(2)S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki T","year":"2019","unstructured":"Panagaki T, Randi EB, Augsburger F, Szabo C. Overproduction of H(2)S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome. Proc Natl Acad Sci U S A. 2019, 116:18769-71. 10.1073\/pnas.1911895116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1086\/321262","article-title":"Homocysteine metabolism in children with Down syndrome: in vitro modulation","volume":"69","author":"Pogribna M","year":"2001","unstructured":"Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet. 2001, 69:88-95. 10.1086\/321262","journal-title":"Am J Hum Genet"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris AA","year":"2017","unstructured":"Morris AA, Ko\u017eich V, Santra S, et al.. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017, 40:49-74. 10.1007\/s10545-016-9979-0","journal-title":"J Inherit Metab Dis"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.690359","article-title":"Health functionalities of betaine in patients with homocystinuria","volume":"8","author":"Truitt C","year":"2021","unstructured":"Truitt C, Hoff WD, Deole R. Health functionalities of betaine in patients with homocystinuria. Front Nutr. 2021, 8:690359. 10.3389\/fnut.2021.690359","journal-title":"Front Nutr"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/chem.200600785","article-title":"Mechanism of the condensation of homocysteine thiolactone with aldehydes","volume":"12","author":"Jakubowski H","year":"2006","unstructured":"Jakubowski H. Mechanism of the condensation of homocysteine thiolactone with aldehydes. Chemistry. 2006, 12:8039-43. 10.1002\/chem.200600785","journal-title":"Chemistry"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1177\/0748233715571152","article-title":"Effect of N-acetylcysteine administration on homocysteine level, oxidative damage to proteins, and levels of iron (Fe) and Fe-related proteins in lead-exposed workers","volume":"32","author":"Kasperczyk S","year":"2016","unstructured":"Kasperczyk S, Dobrakowski M, Kasperczyk A, Romuk E, Rykaczewska-Czerwi\u0144ska M, Pawlas N, Birkner E. Effect of N-acetylcysteine administration on homocysteine level, oxidative damage to proteins, and levels of iron (Fe) and Fe-related proteins in lead-exposed workers. Toxicol Ind Health. 2016, 32:1607-18. 10.1177\/0748233715571152","journal-title":"Toxicol Ind Health"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12085","article-title":"Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine \u03b2-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1\/2 human clinical trial","volume":"42","author":"Van Hove JL","year":"2019","unstructured":"Van Hove JL, Freehauf CL, Ficicioglu C, et al.. Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine \u03b2-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1\/2 human clinical trial. J Inherit Metab Dis. 2019, 42:424-37. 10.1002\/jimd.12085","journal-title":"J Inherit Metab Dis"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2019.12.007","article-title":"Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies","volume":"173","author":"Bublil EM","year":"2020","unstructured":"Bublil EM, Majtan T. Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies. Biochimie. 2020, 173:48-56. 10.1016\/j.biochi.2019.12.007","journal-title":"Biochimie"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171170-hyperhomocysteinemia-and-accelerated-aging-the-pathogenic-role-of-increased-homocysteine-in-atherosclerosis-osteoporosis-and-neurodegeneration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:01:17Z","timestamp":1707490877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171170-hyperhomocysteinemia-and-accelerated-aging-the-pathogenic-role-of-increased-homocysteine-in-atherosclerosis-osteoporosis-and-neurodegeneration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":107,"URL":"https:\/\/doi.org\/10.7759\/cureus.42259","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}